Cargando…
Inter- Not Intraindividual Differences in sTWEAK Levels Predict Functional Deterioration and Mortality in Patients with Dilated Cardiomyopathy
Background. TNF-like weak inducer of apoptosis (TWEAK) has been reported to predict mortality in patients with dilated cardiomyopathy. However, whether it can be used as a biomarker for disease monitoring or rather represents a risk factor for disease progression remains unclear. Aim of the Study. T...
Autores principales: | Jarr, Kai-Uwe, Nelles, Manfred, Katus, Hugo A., Chorianopoulos, Emmanuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4095998/ https://www.ncbi.nlm.nih.gov/pubmed/25089077 http://dx.doi.org/10.1155/2014/576482 |
Ejemplares similares
-
The Diagnostic Value of sTWEAK in Acute Ischemic Stroke
por: Comertpay, Ertan, et al.
Publicado: (2020) -
sTWEAK is a leukoaraiosis biomarker associated with neurovascular angiopathy
por: da Silva‐Candal, Andrés, et al.
Publicado: (2022) -
The presence of leukoaraiosis enhances the association between sTWEAK and hemorrhagic transformation
por: da Silva‐Candal, Andrés, et al.
Publicado: (2020) -
Serum sTWEAK and FGF-23 Levels in Hemodialysis and Renal Transplant Patients
por: Eskandari Naji, H., et al.
Publicado: (2017) -
sTWEAK is a marker of early haematoma growth and leukoaraiosis in intracerebral haemorrhage
por: da Silva-Candal, Andrés, et al.
Publicado: (2021)